158 related articles for article (PubMed ID: 23734707)
1. The human ΔNp53 isoform triggers metabolic and gene expression changes that activate mTOR and alter mitochondrial function.
Lin SC; Karoly ED; Taatjes DJ
Aging Cell; 2013 Oct; 12(5):863-72. PubMed ID: 23734707
[TBL] [Abstract][Full Text] [Related]
2. The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation.
Levandowski CB; Jones T; Gruca M; Ramamoorthy S; Dowell RD; Taatjes DJ
PLoS Biol; 2021 Aug; 19(8):e3001364. PubMed ID: 34351910
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos.
Davidson WR; Kari C; Ren Q; Daroczi B; Dicker AP; Rodeck U
BMC Dev Biol; 2010 Oct; 10():102. PubMed ID: 20929554
[TBL] [Abstract][Full Text] [Related]
4. DeltaNp53 or p44: priming the p53 pump.
Scrable H; Sasaki T; Maier B
Int J Biochem Cell Biol; 2005 May; 37(5):913-9. PubMed ID: 15743665
[TBL] [Abstract][Full Text] [Related]
5. p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53.
Romeo MA; Gilardini Montani MS; Benedetti R; Arena A; D'Orazi G; Cirone M
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33668399
[No Abstract] [Full Text] [Related]
6. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy.
Bristow RG; Benchimol S; Hill RP
Radiother Oncol; 1996 Sep; 40(3):197-223. PubMed ID: 8940748
[TBL] [Abstract][Full Text] [Related]
7. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
Puca R; Nardinocchi L; Gal H; Rechavi G; Amariglio N; Domany E; Notterman DA; Scarsella M; Leonetti C; Sacchi A; Blandino G; Givol D; D'Orazi G
Cancer Res; 2008 May; 68(10):3707-14. PubMed ID: 18483253
[TBL] [Abstract][Full Text] [Related]
8. Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.
Liang Y; Besch-Williford C; Benakanakere I; Hyder SM
Int J Oncol; 2007 Oct; 31(4):777-84. PubMed ID: 17786308
[TBL] [Abstract][Full Text] [Related]
9. Increased mTOR activity and metabolic efficiency in mouse and human cells containing the African-centric tumor-predisposing p53 variant Pro47Ser.
Gnanapradeepan K; Leu JI; Basu S; Barnoud T; Good M; Lee JV; Quinn WJ; Kung CP; Ahima R; Baur JA; Wellen KE; Liu Q; Schug ZT; George DL; Murphy ME
Elife; 2020 Nov; 9():. PubMed ID: 33170774
[TBL] [Abstract][Full Text] [Related]
10. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
Cuddihy AR; Jalali F; Coackley C; Bristow RG
Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
[TBL] [Abstract][Full Text] [Related]
11. Δ40p53 is involved in the inactivation of autophagy and contributes to inhibition of cell death in HCT116-Δ40p53 cells.
Zang Y; Shi Y; Liu K; Qiao L; Guo X; Chen D
Oncotarget; 2017 Feb; 8(8):12754-12763. PubMed ID: 28061446
[TBL] [Abstract][Full Text] [Related]
12. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.
Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S
Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
Snijders AM; Liu Y; Su L; Huang Y; Mao JH
Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
[TBL] [Abstract][Full Text] [Related]
14. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.
Habib NA; Hodgson HJ; Lemoine N; Pignatelli M
Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636
[TBL] [Abstract][Full Text] [Related]
15. Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein.
Vinyals A; Peinado MA; Gonzalez-Garrigues M; Monzó M; Bonfil RD; Fabra A
Gene Ther; 1999 Jan; 6(1):22-33. PubMed ID: 10341872
[TBL] [Abstract][Full Text] [Related]
16. [Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma].
Zhu Z; Lin J; Qu JH; Li FM; Ni CR; Zhu MH
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1795-800. PubMed ID: 14642087
[TBL] [Abstract][Full Text] [Related]
17. The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53.
Shin S; Jing K; Jeong S; Kim N; Song KS; Heo JY; Park JH; Seo KS; Han J; Park JI; Kweon GR; Park SK; Wu T; Hwang BD; Lim K
Biomed Res Int; 2013; 2013():568671. PubMed ID: 23841076
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
[TBL] [Abstract][Full Text] [Related]
19. The role of mitochondria in mTOR-regulated longevity.
Wei Y; Zhang YJ; Cai Y; Xu MH
Biol Rev Camb Philos Soc; 2015 Feb; 90(1):167-81. PubMed ID: 24673778
[TBL] [Abstract][Full Text] [Related]
20. Wild-type p53 binds to MYC promoter G-quadruplex.
Petr M; Helma R; Polášková A; Krejčí A; Dvořáková Z; Kejnovská I; Navrátilová L; Adámik M; Vorlíčková M; Brázdová M
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27634752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
